{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:29:37Z","timestamp":1777087777705,"version":"3.51.4"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.imlet.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T11:34:45Z","timestamp":1605008085000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Progress in research into the role of abnormal glycosylation modification in tumor immunity"],"prefix":"10.1016","volume":"229","author":[{"given":"Hui-min","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-le","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2020.11.003_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2020.11.003_bib0010","doi-asserted-by":"crossref","first-page":"104738","DOI":"10.1016\/j.phrs.2020.104738","article-title":"Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer","volume":"155","author":"Liu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00418-019-01822-3","article-title":"LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells","volume":"153","author":"Hirano","year":"2020","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cellimm.2018.03.008","article-title":"Galectins: multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment","volume":"333","author":"Elola","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2015.03.016","article-title":"Sugar coating: bacterial protein glycosylation and host\u2013microbe interactions","volume":"40","author":"Tan","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.imlet.2020.11.003_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/medicina55120761","article-title":"Increase of MAL-II binding Alpha2,3-Sialylated glycan is associated with 5-FU resistance and short survival of cholangiocarcinoma patients","volume":"55","author":"Wattanavises","year":"2019","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.imlet.2020.11.003_bib0035","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1111\/jcmm.14572","article-title":"Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells","volume":"23","author":"Thomas","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.imlet.2020.11.003_bib0040","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/cddis.2017.363","article-title":"Cancer cell resistance to anoikis: MUC1 glycosylation comes to play","volume":"8","author":"Yu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imlet.2020.11.003_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bpj.2015.11.539","article-title":"Glycosylation affects the conformational behavior of EGFR","volume":"110","author":"Kaszuba","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.imlet.2020.11.003_bib0050","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1038\/onc.2013.308","article-title":"Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells","volume":"33","author":"Raina","year":"2014","journal-title":"Oncogene."},{"key":"10.1016\/j.imlet.2020.11.003_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-\u03b21 induces human alveolar epithelial to mesenchymal cell transition (EMT)","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0060","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/s41598-017-00973-4","article-title":"Dynamics of chromatin accessibility during TGF-\u03b2-induced EMT of Ras-transformed mammary gland epithelial cells","volume":"7","author":"Arase","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2020.11.003_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-015-1684-6","article-title":"Crosstalk of carcinoembryonic antigen and transforming growth factor-beta via their receptors: comparing human and canine cancer [J]","volume":"64","author":"Jensen-Jarolim","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2020.11.003_bib0070","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors","volume":"8","author":"Ribatti","year":"2017","journal-title":"The first theories. Oncotarget"},{"key":"10.1016\/j.imlet.2020.11.003_bib0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/intimm\/dxw014","article-title":"Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment","volume":"28","author":"Spranger","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/138920111798376987","article-title":"Tumor immune escape mechanisms that operate during metastasis","volume":"12","author":"Croci","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.10290","article-title":"MHC class I antigens, immune surveillance, and tumor immune escape","volume":"195","author":"Garcia-Lora","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.seminoncol.2015.05.011","article-title":"The next hurdle in Cancer immunotherapy: overcoming the Non-T-Cell-Inflamed tumor microenvironment","volume":"42","author":"Gajewski","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0110","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","article-title":"Adaptive immune resistance emerges from tumor-initiating stem cells","volume":"177","author":"Miao","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.imlet.2020.11.003_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2020.11.003_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cub.2019.01.003","article-title":"Protein glycosylation","volume":"29","author":"Eichler","year":"2019","journal-title":"Curr. Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.trecan.2018.05.009","article-title":"Glycosylation and integrin regulation in Cancer","volume":"4","author":"Marsico","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.imlet.2020.11.003_bib0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tibs.2015.04.004","article-title":"Glycan variation and evolution in the eukaryotes","volume":"40","author":"Corfield","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.imlet.2020.11.003_bib0135","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.18632\/oncotarget.8155","article-title":"Hallmarks of glycosylation in cancer","volume":"7","author":"Munkley","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.imlet.2020.11.003_bib0140","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1074\/jbc.M115.654483","article-title":"Loss of core 1-derived O-Glycans decreases breast Cancer development in mice","volume":"290","author":"Song","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2020.11.003_bib0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.sbi.2018.12.005","article-title":"Protein O-fucosylation: structure and function","volume":"56","author":"Holdener","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0150","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.bbagen.2016.03.008","article-title":"Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives","volume":"1860","author":"Chia","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imlet.2020.11.003_bib0155","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3350","article-title":"The cell identity of cytotoxic T lymphocytes","volume":"17","author":"Sanin","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.semcancer.2017.03.002","article-title":"Role of protein glycosylation in cancer metastasis","volume":"44","author":"Oliveira-Ferrer","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on glycosylation and its congenital disorders","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.imlet.2020.11.003_bib0180","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00262-011-1012-8","article-title":"Camouflage and sabotage: tumor escape from the immune system","volume":"60","author":"Poschke","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2020.11.003_bib0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","article-title":"Protein glycosylation in cancer","volume":"10","author":"Stowell","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the immune system and the Altered Glycan Theory of Autoimmunity: a critical review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2020.11.003_bib0195","first-page":"519","article-title":"Glycosylation and the Immune System","volume":"17","author":"PM","year":"2001","journal-title":"Science."},{"key":"10.1016\/j.imlet.2020.11.003_bib0200","first-page":"287","article-title":"Effect of Nimesulide on secreting Th1 \/ Th2 cell cytokines of cholangiocarcinoma cell line","volume":"31","author":"Kong","year":"2018","journal-title":"J. Basic Clin. Oncol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0205","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3389\/fimmu.2018.02076","article-title":"Tumor resident memory t cells: new players in immune surveillance and therapy","volume":"9","author":"Dumauthioz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0215","first-page":"2170","article-title":"Advances in research on modification strategies of CTL epitopes of tumor antigens","volume":"24","author":"Huang","year":"2016","journal-title":"Journal of Modern Oncology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour mi- croenvironment [J]","volume":"8","author":"Zou","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0225","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4[J]","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.imlet.2020.11.003_bib0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction proper- ties of costimulatory molecules revisited[J]","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2020.11.003_bib0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7150\/ijbs.4564","article-title":"Complexities of TGF-\u03b2 tar- geted cancer therapy[J]","volume":"8","author":"Connolly","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.imlet.2020.11.003_bib0240","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.f.203","article-title":"Protein-glycan interactions in the control of innate and adaptive immune responses","volume":"9","author":"Van Kooyk","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/366076a0","article-title":"B70 antigen is a second ligand for CTLA-4 and CD28[J]","volume":"366","author":"Azuma","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2020.11.003_bib0250","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1080\/00365521.2018.1532020","article-title":"Higlrdensity and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm [J]","volume":"53","author":"Aronsson","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(98)00460-8","article-title":"Non-glycosylatedhuman B7-1(CD80) retains the capacity to bind its counter-receptors:[J]","volume":"428","author":"Chen A, Meyerson","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.imlet.2020.11.003_bib0260","article-title":"PD-L2 expression in colorectal cancer\u202f:independent prognostic effect and targetability by deglycosylation[J]","volume":"6","author":"Wang","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imlet.2020.11.003_bib0265","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.84.23.8573","article-title":"Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system","volume":"84","author":"Aruffo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2020.11.003_bib0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2004.03.012","article-title":"CD28 T cell cos-timulatory receptor function is negatively regulated by N-linked carbohydrates","volume":"317","author":"Ma","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imlet.2020.11.003_bib0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0280","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1600-0854.2009.00981.x","article-title":"Adaptive regulation at the cell surface by N-glycosylation[J]","volume":"10","author":"Dennis","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.imlet.2020.11.003_bib0285","first-page":"370","article-title":"Exogenetic overexpression of ST3Gal \u2160 increases the ability of adhesion and invasion to ECM in breast Cancer mcf-7 cells","volume":"27","author":"Cui","year":"2011","journal-title":"Chinese Journal of Biochemistry & Molecular Biology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1074-7613(00)80180-6","article-title":"The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis","volume":"12","author":"Priatel","year":"2000","journal-title":"Immunity."},{"key":"10.1016\/j.imlet.2020.11.003_bib0295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/MCB.01750-06","article-title":"Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis","volume":"27","author":"Van Dyken","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0300","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.4049\/jimmunol.180.5.3158","article-title":"Knockdown of Mgat5 inhibits breast Cancer cell growth with activation of CD4+ t cells and macrophages","volume":"180","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0305","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2009.11.098","article-title":"Definitive evidence that a single N-glycan among three glycans on inducible costimulator is required for proper protein trafficking and ligand binding","volume":"391","author":"Kamei","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imlet.2020.11.003_bib0310","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/eji.201746928","article-title":"IL\u20102 is required for the generation of viral\u2010specific CD4+ Th1 tissue\u2010resident memory cells and B cells are essential for maintenance in the lung","volume":"48","author":"Hondowicz","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2020.11.003_bib0320","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/imt-2017-0120","article-title":"PD-1\/PD-L1 in disease","volume":"10","author":"Kuol","year":"2018","journal-title":"Immunotherapy."},{"key":"10.1016\/j.imlet.2020.11.003_bib0330","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/515496a","article-title":"CANCER Antitumour immunity gets a boost","volume":"515","author":"Chan","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Freeman","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fphar.2018.00536","article-title":"Regulation of PD-L1: emerging routes for targeting tumor immune evasion","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imlet.2020.11.003_bib0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Jong-Ho","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.imlet.2020.11.003_bib0355","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.febslet.2013.05.023","article-title":"B-regulatory cells in auto- immunity and immune mediated inflammation[J]","volume":"587","author":"Vadasz","year":"2013","journal-title":"FEBS Let."},{"key":"10.1016\/j.imlet.2020.11.003_bib0360","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0365","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2020.11.003_bib0370","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.4049\/jimmunol.1102173","article-title":"The plasticity of regulatory T cell function","volume":"187","author":"Pillai","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0375","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0380","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature08782","article-title":"B-cell-derived lymphotoxin promotes castration-resistant prostate cancer","volume":"464","author":"Ammirante","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0385","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1101\/gad.220202.113","article-title":"An IKK\u03b1-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence","volume":"27","author":"Ammirante","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0390","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imr.12738","article-title":"The B\u2010cell receptor in control of tumor B\u2010cell fitness: biology and clinical relevance","volume":"288","author":"Casola","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0395","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ni.1903","article-title":"N-linked glycosylation selectively regulates autonomous precursor BCR function","volume":"11","author":"Ubelhart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0400","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4049\/jimmunol.1801622","article-title":"Biased N-Glycosylation site distribution and acquisition across the antibody V region during B cell maturation","volume":"202","author":"Koers","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0405","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fimmu.2018.00820","article-title":"CD22-binding synthetic sialosides regulate B Lymphocyte proliferation through CD22 ligand-dependent and independent pathways, and enhance antibody production in mice","volume":"9","author":"Naoko","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0410","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4049\/jimmunol.1800296","article-title":"Sialic acid ligand binding of CD22 and Siglec-G determines distinct B cell functions but is dispensable for B cell tolerance induction","volume":"201","author":"\u00d6. L","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12344","article-title":"Sialic acids and autoimmune disease","volume":"269","author":"Mahajan","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ni1002-903","article-title":"Sweet\u2019 n\u2019 sour: the impact of differential glycosylation on T cell responses","volume":"3","author":"Daniels","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2018.12.001","article-title":"B cell and B cell-related pathways for novel cancer treatments","volume":"73","author":"Tokunaga","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0430","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-015-1684-6","article-title":"Crosstalk of carcinoembryonic antigen and transforming growth factor-\u03b2 via their receptors: comparing human and canine cancer","volume":"64","author":"Jensen-Jarolim","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2020.11.003_bib0435","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00262-016-1792-y","article-title":"Selection and expansion of natural killer cells for NK cell-based immunotherapy","volume":"65","author":"Becker","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2020.11.003_bib0440","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: an update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0445","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.12526","article-title":"Viewing Siglecs through the lens of tumor immunology","volume":"276","author":"Fraschilla","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0450","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbamcr.2019.03.010","article-title":"Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM\/CD166), synergistically delays in vivo breast cancer growth","volume":"1866","author":"Ferragut","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0455","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ni.3552","article-title":"The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9","volume":"17","author":"Beatson","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0460","doi-asserted-by":"crossref","first-page":"31842","DOI":"10.1074\/jbc.M113.471318","article-title":"Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of \u03b2-catenin and subsequent cell growth","volume":"288","author":"Tanida","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2020.11.003_bib0465","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2020.11.003_bib0470","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/acschembio.6b00433","article-title":"Protein sialylation regulates a gene expression signature that promotes breast Cancer cell pathogenicity","volume":"11","author":"Kohnz","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0475","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.18632\/oncotarget.2698","article-title":"Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells","volume":"6","author":"Desiderio","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.imlet.2020.11.003_bib0485","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1073\/pnas.1608069113","article-title":"Precision glycocalyx editing as a strategy for cancer immunotherapy","volume":"113","author":"Xiao","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.imlet.2020.11.003_bib0490","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1172\/JCI65899","article-title":"Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance","volume":"124","author":"Jandus","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2020.11.003_bib0495","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0014-5793(01)02734-X","article-title":"Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression","volume":"504","author":"Ito","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.imlet.2020.11.003_bib0500","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1074\/jbc.M110146200","article-title":"A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9","volume":"277","author":"Yamaji","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2020.11.003_bib0505","first-page":"40","article-title":"The influence of swainsonine bring in the expression of N-glycan of osteosarcoma tumor stem cells","volume":"33","author":"Zhang","year":"2017","journal-title":"Journal of Practical Medicine."},{"key":"10.1016\/j.imlet.2020.11.003_bib0510","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fimmu.2018.00982","article-title":"Strategies to genetically modulate dendritic cells to potentiate anti-tumor responses in hematologic malignancies","volume":"9","author":"Cornel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0515","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.1998.tb01185.x","article-title":"The C-type lectin superfamily in the immune system","volume":"163","author":"Weis","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.11.003_bib0520","first-page":"53","article-title":"Glycosylation-modified dendritic cell vaccine primes the myeloma-specific T cell response","volume":"1","author":"Hong","year":"2007","journal-title":"Current Immunology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0525","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature."},{"key":"10.1016\/j.imlet.2020.11.003_bib0530","doi-asserted-by":"crossref","first-page":"15764","DOI":"10.1200\/JCO.2019.37.15_suppl.e15764","article-title":"Effect of tumor cell-derived debris and IgG on metastasis of pancreatic cancer and inflammation through tumor-associated macrophages","volume":"37","author":"Zhang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0535","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI130029","article-title":"Functional diversification of IgGs through Fc glycosylation","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2020.11.003_bib0540","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/cancers10110460","article-title":"Fucosyl-agalactosyl IgG1 induces cholangiocarcinoma metastasis and early recurrence by activating tumor-associated macrophage","volume":"10","author":"Chang","year":"2018","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.imlet.2020.11.003_bib0545","first-page":"47","article-title":"Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy","volume":"9","author":"Yusuke","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.imlet.2020.11.003_bib0550","first-page":"35","article-title":"N-Glycosylation of IgG Immunoglobulin and its clinical significance","volume":"4","author":"Maria","year":"2019","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0555","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","article-title":"Immunoglobulin g (IgG) fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes","volume":"13","author":"Bondt","year":"2014","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.imlet.2020.11.003_bib0560","first-page":"249","article-title":"Modified immunoglobulin G glycosylation pattern during turpentine-induced acute inflammation in rats","volume":"62","author":"Andrea","year":"2002","journal-title":"Medicina."},{"key":"10.1016\/j.imlet.2020.11.003_bib0565","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0161-5890(95)00078-S","article-title":"Glycosylation of the variable region of immunoglobulin G\u2014site specific maturation of the sugar chains","volume":"32","author":"Endo","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0570","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10719-011-9364-z","article-title":"Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival","volume":"29","author":"Kodar","year":"2012","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.imlet.2020.11.003_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euprot.2014.11.002","article-title":"The serum immunoglobulin g glycosylation signature of gastric Cancer","volume":"6","author":"Ruhaak","year":"2015","journal-title":"EuPA Open Proteom."},{"key":"10.1016\/j.imlet.2020.11.003_bib0580","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/glycob\/cwm100","article-title":"Ovarian Cancer is associated with changes in glycosylation in both acute-phase proteins and IgG","volume":"17","author":"Radka","year":"2007","journal-title":"Glycobiology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0585","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1021\/pr4003992","article-title":"Quantitative analysis of serum IgG galactosylation assists differential diagnosis of ovarian Cancer","volume":"12","author":"Qian","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0590","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2008\/601583","article-title":"Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis","volume":"25","author":"Radka Saldova","year":"2008","journal-title":"Dis. Markers"},{"key":"10.1016\/j.imlet.2020.11.003_bib0595","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41416-019-0607-2","article-title":"Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation","volume":"121","author":"Hamester","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imlet.2020.11.003_bib0600","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/glycob\/cws108","article-title":"Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins","volume":"22","author":"Vasseur","year":"2012","journal-title":"Glycobiology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0605","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cam4.662","article-title":"Glycosylation status of serum immunoglobulin G in patients with prostate diseases","volume":"5","author":"Kazuno","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.imlet.2020.11.003_bib0610","first-page":"3135","article-title":"Changes in serum IgG oligosaccharide chains with prostate cancer progression","volume":"24","author":"Kanoh","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0615","doi-asserted-by":"crossref","first-page":"1011503","DOI":"10.1080\/2162402X.2015.1011503","article-title":"Elevated core-fucosylated Ig G is a new marker for hepatitis B virus-related hepatocellular carcinoma","volume":"4","author":"Yi","year":"2015","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.imlet.2020.11.003_bib0620","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-Glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2020.11.003_bib0625","first-page":"2988","volume":"64","author":"Sauane","year":"2004","journal-title":"Melanoma differentiation associated gene-7\/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways, Cancer Res."},{"key":"10.1016\/j.imlet.2020.11.003_bib0630","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1002\/eji.200939678","article-title":"IL-24 protects against <em>Salmonella typhimurium<\/em> infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells","volume":"39","author":"Ma","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0635","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0640","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005363","article-title":"Golgi during development","volume":"3","author":"Zhong","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.imlet.2020.11.003_bib0645","first-page":"62","article-title":"Glycosylation of proteins and its application in biological pharmacy","volume":"39","author":"Dong","year":"2012","journal-title":"China Anim. Husb. Vet. Med."},{"key":"10.1016\/j.imlet.2020.11.003_bib0650","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.mib.2013.03.004","article-title":"Fungal glycan interactions with epithelial cells in allergic airway disease","volume":"16","author":"Roy","year":"2013","journal-title":"Curr. Opin. Microbiol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820304089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820304089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:37:50Z","timestamp":1759045070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247820304089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":130,"alternative-id":["S0165247820304089"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.11.003","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in research into the role of abnormal glycosylation modification in tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}